CTRI/2023/06/053547尚未招募3 期
Erythropoietin monotherapy for prevention of mortality after moderate to severe hypoxic ischemic encephalopathy in term neonates in low resource setting- a feasibility study in SMS Medical College
Sawai man singh medical college and attached hospitals0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •For inborns
- •1) Age <= 24 h, gestation >= 36 weeks (based on reported last menstrual period or ultrasound)
- •2) Need for continued resuscitation at 5 min of age and/or 5-min Apgar score < 6
- •3) Evidence of moderate or severe encephalopathy at < 24 h of age on a structured clinical examination based on modified Sarnat staging
- •For outborns
- •1) Age <= 24 h, gestation >= 36 weeks (based on reported last menstrual period or ultrasound)
- •2) Lack of crying by 5 min of age
- •3) Evidence of moderate or severe encephalopathy at < 24 h of age on a structured clinical examination based on modified Sarnat staging
排除标准
- •1) Neonates with congenital anomalies, chromosomal abnormalities, congenital infections, severe intrauterine growth retardation and inborn errors of metabolism
- •2) Imminent death of the newborn before enrolment
研究者
相似试验
尚未招募
Unknown
prophylactic erythropoietiHaematological Disordersanemia in critically ill patientsPACTR201803003169385Asmaa Fawzy Amer100
招募中
不适用
High-dose erythropoietin therapy for the purpose of brain protection in neonatal hypoxic-ischemic encephalopathyHypoxic-ischemic encephalopathyJPRN-UMIN000012689Osaka Medical College20
已完成
3 期
The efficacy of erythropoietin in the treatment of anemia in patients hospitalized in Intensive Care Unit(ICU)Anaemia.Anaemia, unspecifiedIRCT2014071718517N1Vice Chancellor for research of Ardabil University of Medical Sciences70
已完成
不适用
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgeryNL-OMON40254Catharina-ziekenhuis100
进行中（未招募）
不适用
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgeryPatients (male and female) scheduled for coronary artery bypass grafting surgery (CABG) or single Aortic Valve replacement (AVR) on conventional cardiopulmonary bypass.EUCTR2012-002076-14-NL100